Targeted and shallow whole genome sequencing identifies therapeutic opportunities in p53abn endometrial cancers. Jamieson A, Sobral de Barros J, Cochrane DR, Douglas JM, et al. Clin Cancer Res 2024 Mar 27. doi: 10.1158/1078-0432.CCR-23-3689.

Read + Share

Amedeo Smart

Independent Medical Education

Jamieson A, Sobral de Barros J, Cochrane DR, Douglas JM, et al. Targeted and shallow whole genome sequencing identifies therapeutic opportunities in p53abn endometrial cancers. Clin Cancer Res 2024 Mar 27. doi: 10.1158/1078-0432.CCR-23-3689.
PMID: 38536067